NIH Slated for 7 percent Budget Cut
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020. The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors. The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - February 18, 2020 Category: Biology Authors: AIBS Source Type: news

10 African Americans Who Have Shaped  Public Health
By Casey Bishopp, Communications officer, IntraHealth International ; Sabra Farquharson, Business development officer, IntraHealth InternationalFebruary 18, 2020We’re celebrating the legacies of ten African Americans in public health this month—shining a light on the invaluable contributions made by these scholars and health workers. According to themost recent report form the Health Resources and Services Administration, African Americans make up 11.6% of the US health workforce, and throughout American history have made invaluable contributions to greater public health in fields s...
Source: IntraHealth International - February 17, 2020 Category: International Medicine & Public Health Authors: cbishopp Source Type: news

Africa: The Search for an Effective HIV Vaccine Continues
[The Conversation Africa] An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was disappointing, but the search for an effective HIV vaccine continues. Anatoli Kamali speaks to The Conversation Africa's Ina Skosana about other developments in the field. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 17, 2020 Category: Infectious Diseases Source Type: news

Kenya: Hopes Dashed as HIV Vaccine Trial is Cancelled
[Nation] When is was announced that the trials of HVTN 70, an experimental vaccine that could protect people against HIV, the virus that causes Aids, had been cancelled for non-efficacy, Ms Inviolata Mmbavi was disappointed. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 11, 2020 Category: Infectious Diseases Source Type: news

Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV
Women living with HIV who received quadrivalent human papillomavirus (HPV) vaccination still face the risk of infection with non-vaccine oncogenic HPV genotypes, researchers from Canada report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 8, 2020 Category: Pathology Tags: HIV/AIDS News Source Type: news

How Our Modern World Creates Outbreaks Like Coronavirus
“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.” Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a...
Source: TIME: Health - February 7, 2020 Category: Consumer Health News Authors: Mark Honigsbaum Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Africa: Clinical Trial Halted, but Search for HIV Vaccine Continues
[UCT] The early abandonment of HIV vaccine study HVTN 702 (also known as Uhambo) in South Africa for failing to prevent infections is a huge setback in the quest to find an HIV vaccine. However, this will not deter scientists, said the University of Cape Town's (UCT) Professor Linda-Gail Bekker. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - February 5, 2020 Category: Infectious Diseases Source Type: news

Another H.I.V. Vaccine Fails a Trial, Disappointing Researchers
After more than 30 years of research, 1.7 million people are still infected each year with the virus that causes AIDS. (Source: NYT Health)
Source: NYT Health - February 4, 2020 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Acquired Immune Deficiency Syndrome Vaccination and Immunization National Institute for Allergy and Infectious Disease (NIAID) Fauci, Anthony S South Africa Source Type: news

ACIP Updates Recommendations for Adult Vaccines ACIP Updates Recommendations for Adult Vaccines
The ACIP's 2020 guidelines include updated instructions for nuanced shared clinical decision making in certain scenarios.News Alerts (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 3, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

HIV Vaccine Ineffective, Clinical Trial Halted
MONDAY, Feb. 3, 2020 -- A clinical trial for an HIV vaccine has been halted after it was concluded that it did not prevent infection with the AIDS-causing virus, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said Monday. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2020 Category: Pharmaceuticals Source Type: news

HIV vaccine trial ends in 'deep disappointment'
A clinical trial for an HIV vaccine has been discontinued since the vaccine was not found to prevent infections of human immunodeficiency virus, the virus that causes AIDS. (Source: CNN.com - Health)
Source: CNN.com - Health - February 3, 2020 Category: Consumer Health News Source Type: news

Key HIV vaccine trial in South Africa ends because of poor results
Decision described as a ‘significant setback’ by International Aids SocietyThe latest trial of a vaccine against HIV has been halted because interim results show it is not working, the National Institutes of Health in the United States has announced.The end of the trial taking place in South Africa is a blow to the vaccine field and to Aids experts and advocates. As early as the mid-1980s, the US government was forecasting that Aids would be stopped by a vaccine. In 1997, the then-president Bill Clinton pledged money to an effort to find a vaccine within 10 years. But as the decades have passed, no effective va...
Source: Guardian Unlimited Science - February 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Aids and HIV Medical research South Africa US news Science World news Source Type: news

Scientists Hope New Tech Aids Coronavirus Vaccine Scientists Hope New Tech Aids Coronavirus Vaccine
Early trials in people suggest that such a vaccine can stimulate an immune response very well. But it has never been tried during an outbreak.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 28, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Scientists Hope New Tech Aids Coronavirus Vaccine
Early trials in people suggest that such a vaccine can stimulate an immune response very well. But it has never been tried during an outbreak. (Source: WebMD Health)
Source: WebMD Health - January 28, 2020 Category: Consumer Health News Source Type: news

Small Response Gain With Double-Dose Flu Shot in Pregnant Women With HIV Small Response Gain With Double-Dose Flu Shot in Pregnant Women With HIV
Doubling the dose of influenza vaccine for pregnant women with HIV moderately improves immunogenicity compared to a single flu shot, but response remains well below that of pregnant women without HIV, a clinical trial shows.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 16, 2020 Category: Pathology Tags: HIV/AIDS News Source Type: news

Earlens Taps Verily to Help Develop Next-Gen Hearing Solution
Earlens is teaming up with Verily, an Alphabet company, to help develop next-generation capabilities for a nonsurgical hearing solution. Menlo Park, CA-based Earlens said Verily would be a “natural partner.” "By combining our complementary sets of expertise, we aim to develop a next-generation hearing solution, as well as explore modalities for monitoring that may address conditions beyond hearing loss,” Bill Facteau, Earlens president and CEO of Earlens said in a release. The company noted while some acoustic hearing aids have announced new AI capabilities and ove...
Source: MDDI - January 13, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Business Source Type: news

HIV patients lose smallpox immunity despite childhood vaccine, AIDS drugs
(Oregon Health& Science University) HIV patients lose immunity to smallpox even though they were vaccinated against the disease as children and have had much of their immune system restored with antiretroviral therapy, according to a study published in the Journal of Infectious Diseases. Called HIV-associated immune amnesia, the finding could explain why people living with HIV still tend to have shorter lives on average than their HIV-negative counterparts despite being on antiretroviral therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 2, 2020 Category: International Medicine & Public Health Source Type: news

BOMBSHELL: AIDS was developed as a bioweapon and administered through CDC-approved vaccine trials that targeted GAY men in the 1970s
(Natural News) Did you know that, just prior to the HIV and AIDS epidemic that swept the American homosexual population during the early 1980s, the Centers for Disease Control and Prevention (CDC) had conducted a hepatitis B vaccine experiment that’s believed to have triggered it? Between the years of 1978 and 1981, the CDC specifically... (Source: NaturalNews.com)
Source: NaturalNews.com - December 27, 2019 Category: Consumer Health News Source Type: news

Activists and LGBTQ Groups Say These Facebook Ads Spread Dangerous Misinformation About HIV Drugs
Advocacy groups are urging Facebook to remove advertisements that they say unfairly infer that the HIV/AIDS prevention Truvada PrEP (pre-exposure prophylaxis) is dangerous, an allegation they say could endanger the people who are most at risk of contracting the disease. More than 50 HIV/AIDs, LGBTQ and public health advocacy groups released a letter on Monday asking Facebook and Instagram to remove the ads from their platforms. The ads referred specifically to “Truvada PrEP” (the brand name for one of the medications, dtenofovir disoproxil fumarate, used as PrEP) and in some cases more generically to “PrE...
Source: TIME: Health - December 11, 2019 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized health LGBTQ onetime Source Type: news

Multivalent HIV Vaccine Induces Early and Potent Antibody Response Multivalent HIV Vaccine Induces Early and Potent Antibody Response
A multivalent HIV vaccine that consists of envelope protein (gp120 Env) and either DNA or NYVAC vectors during priming leads to early and potent IgG-binding antibody responses, according to results from the HIV Vaccine Trials Network (HVTN).Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 10, 2019 Category: Allergy & Immunology Tags: HIV/AIDS News Source Type: news

Africa: How Close Are We to HIV Cure and Vaccine?
[New Times] Among the avenues that will put healthcare ahead of HIV/Aids is the development of vaccines, cures and multiple prevention mechanisms. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 9, 2019 Category: African Health Source Type: news

UN team aids Samoa response to deadly measles epidemic
UN teams are on the ground in Samoa as the country combats a deadly measles epidemic. So far, there have been more than 4,200 cases and 62 deaths, mainly babies, prompting authorities to declare a state of emergency on 15 November and launch a mass vaccination campaign five days later. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - December 5, 2019 Category: International Medicine & Public Health Source Type: news

Africa: Children and HIV - What We Found About Vaccine-Preventable Diseases
[The Conversation Africa] Sub-Saharan African countries account for about a third of the global burden of vaccine-preventable diseases. These diseases are responsible for a large proportion of deaths in children under the age of five. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - December 4, 2019 Category: Infectious Diseases Source Type: news

Strong Data, Local Relationships: The Future of HIV Care in Tanzania Starts Here
By Margarite Nathe, Principal Editor/Writer, IntraHealth International ; Lucy Mphuru, Country Director& Project Director, Tohara Plus Project Lucy Mphuru (center left) talks with health workers and clients at an IntraHealth-supported mobile clinic in Shinyanga that provides voluntary male circumcision services. Photo by Trevor Snapp for IntraHealth International.November 26, 2019Lucy Mphuru has a big job.Every day, she and her team at IntraHealth International in Tanzania work with frontline health workers and government partners to improve health services in a country of 58 million—1.6 million of whom live...
Source: IntraHealth International - November 26, 2019 Category: International Medicine & Public Health Authors: mnathe Tags: HIV & AIDS Community Engagement Leadership and Governance World AIDS Day Health Workforce Systems Source Type: news

Experimental HIV vaccine successfully elicits broadly neutralizing antibodies to the virus
(Scripps Research Institute) An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains. The tests, in rabbits, showed that these " broadly neutralizing " antibodies targeted at least two critical sites on the virus. Researchers widely assume that a vaccine must elicit bnAbs to multiple sites on HIV if it is to provide robust protection against this ever-changing virus. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 20, 2019 Category: Biology Source Type: news

Tuberculosis Infections Declining, But Not Fast Enough Among Poor, Marginalised: UN Health Agency
A 25 year-old tuberculosis patient is treated at her home in Funafuti, the main island of Tuvalu in the South Pacific. Credit: UNDP Tuvalu/Aurélia Rusek.By External SourceUNITED NATIONS, Oct 17 2019 (IPS) A staggering 1.5 million people died from tuberculosis (TB) last year, the UN health agency said on Thursday, in an appeal for far greater funding and political support to eradicate the curable and preventable disease. Caused by the bacteria Mycobacterium tuberculosis, TB commonly causes persistent coughing, fatigue and weight loss. According to the World Health Organization (WHO) and its latest Global TB Report, a...
Source: IPS Inter Press Service - Health - October 17, 2019 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs Source Type: news

Survey: Many U.S. Adults Not Planning to Get Flu Vaccine
Vaccine knowledge and anticipated rates of vaccination even lower for pneumococcal disease (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 4, 2019 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, Oncology, Pathology, Pediatrics, Pharmacy, Pulmonology, Rheumatology, Institutional, Source Type: news

UN Welcomes ‘Most Comprehensive Agreement Ever’ on Global Health
In conclusion, he pointed to the “profound” challenges we face, saying: “I am confident that if we continue and strengthen international co-operation and seize the opportunities already available, while creating even more opportunities, we can overcome them – together”.   ‘A political choice’ Universal health coverage means all people regardless of their ability to pay, having access to the health care they need, when and where they need it, without facing financial hardship. Congratulating world leaders, Tedros Adhanom Ghebreyesus, Director-General at the World Health Or...
Source: IPS Inter Press Service - Health - September 24, 2019 Category: International Medicine & Public Health Authors: External Source Tags: Development & Aid Global Headlines Health Human Rights Source Type: news

Rwanda: Global Researchers Bring HIV Vaccine Discussions to Rwanda
[New Times] Global experts are going to share research on HIV vaccines and cures in a meeting that will bring together over ten thousand delegates in Kigali in December. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - August 25, 2019 Category: Infectious Diseases Source Type: news

Burundi: Govt Launches Ebola Vaccination Campaign for Health and Front-Line Workers
[WHO] On 13th August, the Ministry of Public Health and AIDS Control kicked off the vaccination campaign for front-line staff against the Ebola virus disease. The campaign started at the Gatumba entry point at the Border with the Democratic Republic of Congo. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 15, 2019 Category: African Health Source Type: news

Duke banks $129 million in federal funding for HIV vaccine development
Thanks to a $129 million federal grant, the Duke Human Vaccine Institute (DHVI) will continue its now 14-year long effort to develop a vaccine for HIV. The National Institute of Allergy and Infectious Disease has announced a seven-year grant totaling at least $129 million to the DHVI. Under the terms of the grant, the institute could also award an additional $18 million – potentially bringing funding to $147 million.  The grants fund the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD)… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 10, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Scripps Research-led consortium awarded $129 million from NIH for new HIV vaccine approach
(Scripps Research Institute) The Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 10, 2019 Category: Infectious Diseases Source Type: news

Zimbabwe: 500 People for New HIV Drug Trials
[The Herald] Zimbabwe has become the first country in the Sub-Saharan Africa region to complete the successful enrolment of participants who are taking part in the ongoing large-scale HIV vaccine efficacy trials which are currently underway on four continents, covering 12 countries with about 12 669 study participants on board. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 8, 2019 Category: Infectious Diseases Source Type: news

Tanzania: HIV Vaccine Trial One Step Up
[Daily News] THE Muhimbili University of Health and Allied Sciences (MUHAS), has embarked on the third stage of HIV vaccine trials involving participants who are at high risk of contracting the disease. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 4, 2019 Category: Infectious Diseases Source Type: news

More HPV vaccinations could prevent cancer in 1,300 Californians
FINDINGSBased on a 2017 rate of vaccination against HPV among a group of California 20-year-olds, researchers estimate that this group is at risk for an excess of 1,352 cases of cancer that could be prevented with a 99.5% vaccination rate. Treatment for these preventable cancers would cost the health care system $52.2 million. The size of the group was 296,525 people, the approximate number of 20-year-olds in California in 2017.BACKGROUNDHuman papillomavirus, or HPV, is the most common sexually transmitted infection in the United States and is linked to seven types of cancer: cervical, vaginal, vulvar, penile, rectal, anal...
Source: UCLA Newsroom: Health Sciences - July 2, 2019 Category: Universities & Medical Training Source Type: news

Flu Shot Weak This Season, Recs for Catch-up HPV Vaccines : CDC Flu Shot Weak This Season, Recs for Catch-up HPV Vaccines : CDC
A CDC advisory panel stated that this past season's flu vaccine was only about 30% effective, while recommending a decision-making process for those aged 27 to 45 years to get catch-up vaccinations for HPV.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 29, 2019 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Half of H.I.V. Patients Are Women. Most Research Subjects Are Men.
Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever. (Source: NYT Health)
Source: NYT Health - May 28, 2019 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Women and Girls Acquired Immune Deficiency Syndrome Clinical Trials Drugs (Pharmaceuticals) American Foundation for AIDS Research Immune System Estrogen your-feed-science your-feed-healthcare Source Type: news

HIV Vaccine Awareness Day 2019 — May 18, 2019
Statement by Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, and Maureen M. Goodenow, Ph.D., NIH Associate Director for AIDS Research and Director, Office of AIDS Research (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 17, 2019 Category: American Health Source Type: news

What Are Barriers and Facilitators of Transitioning Youth to an Adult Health Care Provider?
Discussion Transitioning patients within or across health care facilities is a complex process. It is not a single step or point in time. For many patients the transition from pediatric to adult health care can be uncomplicated as patients and health care providers are ready for the transition and are seeking it. It should be a part of “developmental milestone” for adolescent visits. Asking adolescents about their future plans especially after high school or college often easily segues into this discussion easily. For other patients and families, there is anxiety and fear about the transition process. For yout...
Source: PediatricEducation.org - May 13, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

‘Conclusive evidence’ that antiretroviral therapy wards off HIV transmission
Even when condoms not used during sex, reveals study of nearly 1000 gay male couples Related items fromOnMedica HPV programme linked to dramatic fall in cervical disease HIV therapy helps protect men from Hep B infection Promise to end new HIV transmissions in England by 2030 JCVI recommends universal HPV vaccination Experts warn approach to HIV/AIDS is complacent (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 3, 2019 Category: UK Health Source Type: news

HAV Infection Among Previously Vaccinated Persons With HIV HAV Infection Among Previously Vaccinated Persons With HIV
This report indicates that previous vaccination for hepatitis A did not reliably provide protection among some persons with HIV infection.Morbidity & Mortality Weekly Report (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 1, 2019 Category: Allergy & Immunology Tags: HIV/AIDS Journal Article Source Type: news

Cameroon: Fight Against HIV, STIs - Social Vaccine Caravan in Ngoumou
[Cameroon Tribune] Under the patronage of the First Lady, the Governor of the Centre Region has launched the campaign to curb HIV/STIs in the Mefou and Akono Division. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - April 30, 2019 Category: Infectious Diseases Source Type: news

Global Health: Widespread Testing Begins on Malaria Vaccine That Is Only Partly Effective
Despite the vaccine ’ s drawbacks, the W.H.O. endorsed testing on 360,000 children, in an effort to lower death rates in Africa. (Source: NYT Health)
Source: NYT Health - April 24, 2019 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Vaccination and Immunization Malaria Mosquitoes Clinical Trials GlaxoSmithKline PLC Gavi, the Vaccine Alliance Global Fund to Fight AIDS, Tuberculosis and Malaria Sanaria Inc World Health Organization Unitaid Africa Equatorial Guinea Source Type: news

Notes from the Field: Acute Hepatitis A Virus infection Among Previously Vaccinated Persons with HIV Infection --- Tennessee, 2018
Among 249 confirmed cases of hepatitis A virus infection, 4% occurred among persons with human immunodeficiency virus infection. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 11, 2019 Category: American Health Tags: Hepatitis A HIV/AIDS MMWR Morbidity & Mortality Weekly Report Source Type: news

Medical News Today: New HIV vaccine could expose latent virus and kill it
Using immune cells in an innovative way, scientists just got closer to developing an HIV vaccine that could make antiretroviral drugs a thing of the past. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2019 Category: Consumer Health News Tags: HIV and AIDS Source Type: news

AACR: HPV Vax Low for Adults at High Risk for HIV Infection
Age, sex, sexual orientation differences in HPV vaccination rates were statistically significant (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 3, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, AIDS, Internal Medicine, Nursing, Oncology, Pharmacy, Conference News, Source Type: news

How HIV Might Influence HPV Vaccination Rates
TUESDAY, April 2, 2019 -- Does being at high risk for HIV mean you're less likely to get the human papillomavirus (HPV) vaccine? New research suggests that's so. HIV is the virus that causes AIDS, while HPV can cause cervical, anal and other... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 2, 2019 Category: General Medicine Source Type: news

Adults at high risk for HIV infection have low rates of vaccination against HPV
(American Association for Cancer Research) Adults who are at high risk of becoming infected with the human immunodeficiency virus (HIV), which causes AIDS, were less likely than the general population to be vaccinated against human papillomavirus (HPV), which can cause anal and cervical cancer, according to results presented at the AACR Annual Meeting 2019, held in Atlanta March 29-April 3. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 2, 2019 Category: International Medicine & Public Health Source Type: news

Senegal ’s New eLearning Platform Helps Prevent Service Disruptions as Health Workers Train
By Moussa Dia, Technical advisor for health systems performance, IntraHealth InternationalMarch 21, 2019Unlike other online platforms, it covers several areas of care and is useful for all types of health workers.en fran çaisMaty* is the only nurse in her remote village in Senegal. When she travels to the health district for training —which she must do frequently—it means there are no qualified medical personnel in her village to care for pregnant women, deliver babies, treat sicknesses, or respond to medical emergencies.If she ’s gone and her clients need help, they must either wait or go to ano...
Source: IntraHealth International - March 21, 2019 Category: International Medicine & Public Health Authors: mnathe Tags: Neema Digital Health Mobile Technology Education & Performance eLearning Management and Performance Nurses Senegal Source Type: news

Computer-designed vaccine elicits potent antibodies against RSV
(University of Washington Health Sciences/UW Medicine) A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus, a major cause of infant mortality worldwide, has been developed through computer design. Animal tests suggest the vaccine could provide potent, durable protection against RSV. The vaccine is being further developed for possible clinical trials. The nanoparticle platform will also be used to design potential vaccines for AIDS, hepatitis C and cancer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 7, 2019 Category: Infectious Diseases Source Type: news